Method for Retrovirus Removal
US-2017173511-A1 · Jun 22, 2017 · US
US10675588B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10675588-B2 |
| Application number | US-201615561579-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 17, 2016 |
| Priority date | Apr 17, 2015 |
| Publication date | Jun 9, 2020 |
| Grant date | Jun 9, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Embodiments described herein relate to electrospun nanofiber ultrafiltration membrane compositions capable of operating in tangential filtration mode and methods of using the same.
Opening claim text (preview).
What is claimed is: 1. Method of purifying a biological material of interest in a sample comprising: a. providing a sample containing the biological material of interest having a molecular weight equal to or greater than 500 K Da, wherein the biological material of interest is selected from a therapeutic protein, a conjugated polysaccharide vaccine and a virus-like particle; b. contacting the sample in tangential filtration (TFF) mode with an electrospun nanofiber membrane composition comprising nylon nanofibers having an average fiber diameter less than 15 nm, thereby resulting in a permeate and a retentate; and c. collecting the retentate containing the biological material of interest, thereby purifying the biological material of interest. 2. The method of claim 1 , wherein the method results in an increase in the concentration of the biological material of interest. 3. The method of claim 1 , wherein the electrospun nanofiber composition exhibits a higher water permeability in TFF mode compared to a solution cast polymeric membrane. 4. The method of claim 1 , wherein the electrospun nanofiber membrane composition exhibits a higher flux in TFF mode compared to a solution cast polymeric membrane. 5. The method of claim 1 , wherein the collecting step comprises diafiltration. 6. The method of claim 1 , wherein the electrospun nanofiber membrane composition is made from Nylon-6. 7. The method of claim 1 , wherein the purified biological material of interest has a 90% yield or greater than 90% yield. 8. The method of claim 1 , wherein the electrospun nanofiber membrane composition is incorporated into a device suitable for TFF. 9. The method of claim 8 , wherein the device is a cassette or a spiral wound device.
Polyureas; Polyurethanes · CPC title
comprising nanofibres · CPC title
Ultrafiltration · CPC title
Diafiltration · CPC title
by agglomeration of particles · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.